The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
On July 30, major companies reported mixed quarterly results and updated financial outlooks, with Sanofi raising its 2026 guidance following strong Q2 growth driven by Dupixent. Xerox also increased its full-year projections following the Lexmark acquisition, while Neogen reported a 4.3% core revenue growth. Conversely, Pharming Group lowered its annual revenue outlook by $30 million due to declining sales of its RUCONEST therapy.